OESIL Score for Syncope

OESIL Score
Age >65 Years
History of Cardiovascular Disease
Syncope Without Prodrome
Abnormal ECG
OESIL Score:0
Estimates 12-month all-cause mortality in patients presenting with syncope.

Why Use

Provides a simple risk stratification tool to predict 1-year all-cause mortality after a syncopal episode, helping to identify patients at higher risk who may need a more aggressive evaluation and treatment. Assists ED disposition decisions (admission vs. discharge) and potentially avoids unnecessary hospitalizations for low-risk patients.

When to Use

Use in the evaluation of adult patients presenting with syncope in the emergency department (ED). Particularly useful for risk stratification when the etiology of syncope is unclear after initial assessment.

Formula

Addition of the selected points: Item Points Age >65 years +1 Cardiovascular disease in clinical history* +1 Syncope without prodrome +1 Abnormal EKG** +1 *Cardiovascular disease was defined as any of the following: Previous clinical or laboratory diagnosis of any form of structural heart disease, including ischemic heart disease, valvular dysfunction, and primary myocardial disease. Previous diagnosis or clinical evidence of congestive heart failure. Previous diagnosis or clinical evidence of peripheral arterial disease. Previous diagnosis of stroke or TIA. **Abnormal EKG was defined as any of the following: Rhythm abnormalities (atrial fibrillation or flutter, supraventricular tachycardia, multifocal atrial tachycardia, frequent or repetitive premature supraventricular or ventricular complexes, sustained or non-sustained ventricular tachycardia, paced rhythms). Atrioventricular (AV) or intraventricular conduction disorders (complete AV block, Mobitz I or Mobitz II AV block, bundle branch block, or intraventricular conduction delay). Left or right ventricular hypertrophy. Left axis deviation. Old myocardial infarction. ST segment and T wave abnormalities consistent with or possibly related to myocardial ischemia. Non-specific repolarization abnormalities were not considered abnormal.

Pearls / Pitfalls

Not appropriate for use in patients with significant underlying pathology and does not differentiate between specific causes of syncope (e.g., cardiac vs. neurogenic). Designed to be used at the time of initial presentation to the ED; results may not be reliable if applied in other clinical settings or situations. Developed and validated in patients aged ≥12 years. The derivation study excluded patients with known seizure disorders, those presenting with presyncope, dizziness, or vertigo, and those without a clear loss of consciousness.

Management

Low risk (score 0–1): Consider further outpatient evaluation and follow-up. Provide patient education on warning signs and when to return to the ED. Intermediate to high risk (score ≥2): Consider hospital admission for further monitoring and investigation (e.g., telemetry, echocardiography). Initiate consultations with cardiology or neurology as needed.

Advice

This tool complements, but does not replace, clinical judgment, a careful history, and a thorough evaluation of syncope patients in the ED.

More Information

Interpretation: OESIL Score Mortality 0 points 0% 1 point 0.8% 2 points 19.6% 3 points 34.7% 4 points 57.1%

Oh hi there 👋
It’s nice to meet you.

New scoring tools, dose references, and guideline summaries straight to your inbox.

We don’t spam! Read our privacy policy for more info.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *